通过SIMPRO研究联盟在肿瘤临床实践中实施患者报告结局进行症状管理:一项实用性II型混合效果-实施多中心整群随机阶梯楔形试验的研究方案
该研究方案描述SIMPRO联盟开发并测试电子症状管理项目(eSyM),该项目整合于Epic电子健康记录系统,支持患者实时症状追踪、临床医生严重症状自动提醒及群体管理专门报告。采用实用性阶梯楔形整群随机试验设计,主要结局为开始化疗或手术后出院30天内急诊科治疗即离院事件的发生率,次要结局包括住院率、化疗使用及患者生活质量和满意度,同时评估实施促进与障碍因素。
要点
- eSyM整合于Epic电子健康记录系统,支持实时症状追踪、严重症状自动提醒及群体管理报告。
- 采用实用性阶梯楔形整群随机试验,主要结局为化疗开始或术后出院30天内急诊科治疗即离院事件。
- 作为II型混合效果-实施研究,全程评估实施的促进与障碍因素。
核心结论
- 该试验将在常规诊疗环境中评估eSyM,其务实设计有望产出关于电子健康记录整合的、基于ePRO的症状管理项目的采纳、可接受性和影响的普适性结果。
研究设计与样本
- SIMPRO是由美国6个卫生系统 investigator 组成的多学科团队,旨在开发、测试并整合面向肿瘤内科和外科患者的电子症状管理项目(eSyM)至Epic电子健康记录系统及关联患者门户。
- eSyM通过实用性阶梯楔形整群随机试验部署,作为II型混合效果-实施研究,全程评估实施的促进与障碍因素。
主要发现
- eSyM支持患者实时症状追踪、临床医生严重症状自动提醒以及促进群体管理的专门报告。
- 主要研究结局为开始化疗或手术后出院30天内急诊科治疗即离院事件的发生情况。
- 次要结局包括住院率、化疗使用(开始时间和治疗持续时间)以及患者生活质量和满意度。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, not proactive, and doctor-patient communication is often suboptimal. As a result, symptomatic patients may suffer between clinic visits. In research settings, systematic assessment of electronic patient-reported outcomes (ePROs), coupled with clinical responses to severe symptoms, has eased this symptom burden, improved health-related quality of life, reduced acute care needs, and extended survival. Implementing ePRO-based symptom management programs in routine care is challenging. To study methods to overcome the implementation gap and improve symptom control for cancer patients, the National Cancer Institute created the Cancer-Moonshot funded Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium. METHODS: Symptom Management IMplementation of Patient Reported Outcomes in Oncology (SIMPRO) is one of three research centers that make up the IMPACT Consortium. SIMPRO, a multi-disciplinary team of investigators from six US health systems, seeks to develop, test, and integrate an electronic symptom management program (eSyM) for medical oncology and surgery patients into the Epic electronic health record (EHR) system and associated patient portal. eSyM supports real-time symptom tracking for patients, automated clinician alerts for severe symptoms, and specialized reports to facilitate population management. To rigorously evaluate its impact, eSyM is deployed through a pragmatic stepped wedge cluster-randomized trial. The primary study outcome is the occurrence of an emergency department treat-and-release event within 30 days of starting chemotherapy or being discharged following surgery. Secondary outcomes include hospitalization rates, chemotherapy use (time to initiation and duration of therapy), and patient quality of life and satisfaction. As a type II hybrid effectiveness-implementation study, facilitators and barriers to implementation are assessed throughout the project. DISCUSSION: Creating and deploying eSyM requires collaboration between dozens of staff across diverse health systems, dedicated engagement of patient advocates, and robust support from Epic. This trial will evaluate eSyM in routine care settings across academic and community-based healthcare systems serving patients in rural and metropolitan locations. This trial's pragmatic design will promote generalizable results about the uptake, acceptability, and impact of an EHR-integrated, ePRO-based symptom management program. TRIAL REGISTRATION: ClinicalTrials.gov NCT03850912 . Registered on February 22, 2019. Last updated on November 9, 2021.
引用
- Hassett MJ, Wong S, Osarogiagbon RU, et al. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial. Trials. 2022. PMID: 35710449. doi:10.1186/s13063-022-06435-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。